中文名称: | Sorivudine 一键复制产品信息 | ||||
---|---|---|---|---|---|
英文名称: | Sorivudine | ||||
别名: | 索立夫定 BV-araU | ||||
CAS No: | 77181-69-2 | 分子式: | C11H13BrN2O6 | 分子量: | 349.13 |
CAS No: | 77181-69-2 | ||||
分子式: | C11H13BrN2O6 | ||||
分子量: | 349.13 |
基本信息
产品编号:S10773 |
|||||
产品名称:Sorivudine |
|||||
CAS: |
77181-69-2 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
六个月 |
||
分子量 |
349.13 |
-20℃ |
一个月 |
||
化学名: |
|||||
Solubility (25°C) |
体外 |
DMSO |
100mg/mL (286.43mM; Need ultrasonic) |
||
Ethanol |
|
||||
Water |
|
||||
体内 |
现配现用 |
|
|||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
2.8643mL |
14.3213mL |
28.6426mL |
5mM |
0.5729mL |
2.8643mL |
5.7285mL |
10mM |
0.2864mL |
1.4321mL |
2.8643mL |
生物活性
产品描述 |
一种口服活性的,合成的嘧啶核苷抗代谢 (pyrimidine nucleoside antimetabolite) 药物。 |
靶点/IC50 |
DNA/RNA Synthesis |
体外研究 |
Sorivudine (BV-araU) inhibits strains of HSV-1 and HSV-2 (wild-type strains VR-3 and UW-268) with ID50s (50% inhibitory dose) of 0.39 and 0.67μM, respectively. Sorivudine has antiviral activity against several viruses including varicella zoster virus, herpes simplex type 1 virus, and Epstein-Barr virus. Sorivudine (BV-araU) is a pyrimidine nucleoside analog which has in vitro inhibitory activity against varicella zoster virus (VZV) at concentrations of 00001-0.004 mg/ml These concentrations are over 1000-fold lower than those which are required for the inhibition of VZV replication by acyclovir 3 Sorivudine also inhibits HSV-I replication at concentrations ranging from 0.03-0.1mg/ml. |
体内研究 |
Sorivudine (BV-araU) has been evaluated in the treatment of HSV-l encephalitis when administered orally to mice. At dosages in excess of 12.5mg/kg, survival of treated mice is prolonged. With doses in excess of 50mg/kg, a significant decrease in mortality was achieved as we1l. A more relevant model is that of simian varicella virus infection in African green monkeys (Cerophithecus aethiops). In this system, Sorivudine therapy at dosages as low as 20mg/kg per day given intramuscularly or 100mg/kg per day administered orally completely protected against viremia and mortality. In the conduct of these studies, there was no evidence of neurotoxicity or abnormalities in hematology or clinical chemistries. Doses as low as 0.2mg/kg per day were effective; however, breakthrough viremia was noted at lower dosages |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )